Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Rodriguez-Alen A, Moscardo A, Bastida JM, Rivera J. Molecular Pathogenesis of Inherited Platelet Dysfunction. Biomolecules. 2025 Oct 30;15(11):1528. doi: 10.3390/biom15111528. PubMed PMID: 41301446; PubMed Central PMCID: PMC12649936.
AÑO: 2025; IF: 4.8
Lloret-Madrid P, Boluda B, Martinez-Lopez J, Bergua J, Rodriguez Arboli E, Labrador J, Sossa C, Gil C, Algarra L, Lavilla-Rubira E, Serrano J, de Rueda B, Ibanez F, Gonzalez Gonzalez BJ, Amigo ML, Garcia Belmonte D, Rodriguez-Medina C, Gomez-Roncero MI, Colorado M, Lopez Lorenzo JL, Tormo M, Arce Fernandez O, Cano-Ferri I, Solana-Altabella A, Foncillas MA, Alfonso Pierola A, Vives S, Nunez MV, Lopez-Vidal H, Perez-Santaolalla E, Hermosin Ramos L, Garcia Boyero R, Llorente Gonzalez L, Roldan A, Calderon SC, Infante JB, Olave T, Garcia-Suarez J, de Laiglesia A, Rodriguez-Veiga R, Trigo F, Martinez-Cuadron D, Montesinos P. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study. Cancer. 2025 Jan 1;131(1):e35696. doi: 10.1002/cncr.35696. PubMed PMID: 39748608.
AÑO: 2025; IF: 5.1
Vedovati MC, Munoz Martin AJ, Giustozzi M, Jimenez-Fonseca P, Becattini C, Martinez Del Prado MP, Dentali F, Huisman MV, Cohen AT, Bauersachs R, Carmona-Bayonas A, Agnelli G. Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism. Eur J Intern Med. 2025 Jul;137:67-72. doi: 10.1016/j.ejim.2025.04.016. Epub 2025 Apr 18. PubMed PMID: 40253230.
AÑO: 2025; IF: 6.1
Iglesias-Perez C, Jimenez-Fonseca P, Lopez Robles J, Garcia Adrian S, Fernandez Perez I, Martinez Del Prado P, Rubio Perez J, Martinez de Castro E, Diaz Pedroche C, Garcia de Herreros M, Carmona Campos M, Ruperez Blanco AB, Salgado Fernandez M, Quintanar Verduguez T, Marrupe Gonzalez D, Covela Rua M, Santiago Crespo JA, Nieva Munoz M, Munoz A, Carmona-Bayonas A. Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry. Thromb Res. 2025 Dec;256:109525. doi: 10.1016/j.thromres.2025.109525. Epub 2025 Nov 3. PubMed PMID: 41237754.
AÑO: 2025; IF: 3.4
Munarriz D, Lopez-Godino O, Martinez-Cibrian N, Albiol N, Brillembourg H, Navarro-Velazquez S, Espanol-Rego M, Casanueva S, Garcia-Tomas L, Munoz-Sanchez G, Alserawan L, Benitez-Ribas D, Magnano L, Correa JG, Rivero A, Mozas P, Gine E, Rodriguez-Lobato LG, Martinez-Roca A, Montoro-Lorite M, Ayora P, Esteve J, Frutos L, Balague-Ponz O, Urbano-Ispizua A, Gonzalez-Navarro EA, Juan M, Delgado J, Ortiz-Maldonado V. Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. Int J Mol Sci. 2025 Sep 23;26(19):9265. doi: 10.3390/ijms26199265. PubMed PMID: 41096533; PubMed Central PMCID: PMC12524146.
AÑO: 2025; IF: 4.9
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL